Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL Laying off?

That's why, IMO, any ascertion that the current feud "isn't" affecting licensing efforts would seem illogical. If we don't see a substantial rise in licensing within the next 30-45 days, I feel safe saying the impact is real. After all, everyone (including infringers) are aware of the NIRC. Let's be real here, anyone on notice had many months to evaluate the notice of infringement from Alliacense. If the pending NIRC doesn't get them of their butts, what will? I would assume some of them prefer the court house unless we are able to make an example out of the T3.

Share
New Message
Please login to post a reply